Stem Cells to Treat Fractures in France
Project REBORNE will commence clinical trials to help repair fractured bone in France. Following successful pre-clinical work and approval by the French Medicinal Agency, autologous mesenchymal stem cells in combination with a biomaterial will be transplanted into the fracture sites of 30 patients. Ultimately, the researchers hope to expand the study to other European centers to demonstrate the safety and tolerability of this intervention.